MyMyelomaTeam

Why does an oncologist keep monitoring beta-2 microglobulin levels after a second IgG M spike was found?

Great question! Beta-2 microglobulin (B2M) is one of the most important markers your oncologist uses to understand how active myeloma is in your body. When a second M spike appears, it signals that myeloma activity may be Show Full Answer

Why does an oncologist keep monitoring beta-2 microglobulin levels after a second IgG M spike was found?

Great question! Beta-2 microglobulin (B2M) is one of the most important markers your oncologist uses to understand how active myeloma is in your body. When a second M spike appears, it signals that myeloma activity may be increasing, making it even more critical to track. Here's why your oncologist watches B2M so closely:

- Staging — B2M levels are a key part of the R-ISS staging system used to determine how advanced myeloma is
- Disease activity — Rising B2M can indicate myeloma is becoming more active
- Treatment decisions — High B2M levels, especially above 5.5 mg/L, can influence when and how to treat
- Monitoring response — Changes in B2M help show whether treatment is working or if the disease is progressing

Think of B2M as one of myeloma's "report cards" — your oncologist is keeping a close eye on the grades to stay ahead of any changes. Always discuss what your specific numbers mean with your care team, as they'll interpret results alongside your full picture.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Stage 3 Multiple Myeloma: Outlook and Survival

IgG and IgA Antibodies in Myeloma: Which Is More Aggressive?